Mingxue Li
Key Laboratory Of Structure Based Drug Design & Discovery
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer.
Journal: Acta pharmaceutica Sinica. B
Published: September 23, 2022
Entrectinib, a new multi-target inhibitor for cancer therapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 18, 2022
Erratum to "Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1" [Bioorg. Med. Chem. 36 (2021) 116095].
Journal: Bioorganic & medicinal chemistry
Published: February 15, 2022
Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: July 01, 2021
Discovery of metal-based complexes as promising antimicrobial agents.
Journal: European journal of medicinal chemistry
Published: April 27, 2021
Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1.
Journal: Bioorganic & medicinal chemistry
Published: January 23, 2021
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 09, 2020
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
Journal: Acta pharmaceutica Sinica. B
Published: February 12, 2020
Structure based discovery of novel hexokinase 2 inhibitors.
Journal: Bioorganic chemistry
Published: December 05, 2019
Bcl-XL: A multifunctional anti-apoptotic protein.
Journal: Pharmacological research
Published: July 25, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026